General MedicationsINJECTIONGeneric

SELENIOUS ACID

Standard Dose

60UG/1ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: None (Tentative Approval)

Summary

Approval overview SELENIOUS ACID is listed in Drugs@FDA under application 220051 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SELENIOUS ACID Form and strength INJECTION - 60UG/1ML Sponsor BPI LABS LLC Submission history Latest submission status date: 2026-01-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview SELENIOUS ACID is listed in Drugs@FDA under application 220051 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SELENIOUS ACID Form and strength INJECTION - 60UG/1ML Sponsor BPI LABS LLC Submission history Latest submission status date: 2026-01-07 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.